Endothelial dysfunction as a predictor of hypercoagulable disorders in patients with COPD

E. Abduganieva (Tashkent, Uzbekistan), N. Gafner (Tashkent, Uzbekistan)

Source: International Congress 2019 – Clinical problems
Session: Clinical problems
Session type: Thematic Poster
Number: 628
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Abduganieva (Tashkent, Uzbekistan), N. Gafner (Tashkent, Uzbekistan). Endothelial dysfunction as a predictor of hypercoagulable disorders in patients with COPD. 628

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endothelial dysfunction at the patients with COPD with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001

Endothelial dysfunction of patients with pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002

Pulmonary hypertension and endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007

Evaluation of endothelial dysfunction at the patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 316s
Year: 2004

Endothelial dysfunction in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011


Correction of endothelial dysfunction in patients with COPD, IPF
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010


Correction of endothelial dysfunction in patients with pulmonary diseases
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008


Vascular dysfunction and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - COPD: human studies
Year: 2011


Endothelial dysfunction in patients with occupational lung diseases
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010


Endothelial function in patients with pulmonary diseases
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008


Endothelial dysfunction as systemic effects of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006

Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007

Correction of endothelial dysfunction in patients with COPD and concomitant arterial hypertension
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial
Source: Eur Respir J, 50 (4) 1701183; 10.1183/13993003.01183-2017
Year: 2017



Systemic inflammation and vascular dysfunction in patients with OSA
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011


Hypoxaemia and endothelial dysfunctional in patients with COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Endothelial dysfunction in hematological disorders
Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy
Year: 2016

Endothelial dysfunction in stable COPD – a link between systemic inflammation and cardiovascular morbidity?
Source: Eur Respir J 2006; 28: Suppl. 50, 116s
Year: 2006

Systemic inflammation and endothelial dysfunction in patient with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 143s
Year: 2007

Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018